Status:
UNKNOWN
Effects of Aromatherapy for Older Adults at Risk of Metabolic Syndrome in the Community
Lead Sponsor:
National Taipei University of Nursing and Health Sciences
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Background: According to statistics, Taiwan will become a super-aged society in 2025, and health promotion and care for the elderly are important issues of public health. With the prolongation of life...
Detailed Description
Objective: The purpose of this study is to understand the sleep status and quality of life of the older adults at risk of metabolic syndrome in the community and the potential contributing factors, an...
Eligibility Criteria
Inclusion
- Students aged 65 or above in community care bases 2. People with normal sense of smell 3. No severe respiratory disease 4. Have any one of the metabolic syndrome risk factors
- According to the definition of the National Health Service:
- Abdominal obesity: waist circumference ≧90cm for men, waist circumference ≧80cm for women;
- High blood pressure: systolic blood pressure ≧ 130mmHg or diastolic blood pressure ≧ 85mmHg, or taking medication for hypertension prescribed by a doctor;
- High fasting blood sugar: fasting blood sugar ≧100mg/dL, or taking a doctor's prescription for diabetes treatment;
- High fasting triglycerides: ≧150mg/dL, or taking medicines for lowering triglycerides prescribed by doctors;
- Low high-density lipoprotein cholesterol: men \<40mg/dL, women \<50mg/dL, the above five items are risk factors, and three or more items are met as metabolic syndrome.
- 5\. Complaints of sleep disorders 6. Those who agree and can cooperate with research activities
Exclusion
- Those who are allergic to essential oils
- Diagnosed with dementia, mental illness: such as depression
- Cancer patients
- Those who are currently using aromatherapy/have participated in or used aromatherapy-related activities within one month
- Currently there is a wound on the shoulder and neck
Key Trial Info
Start Date :
September 19 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2024
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT05987020
Start Date
September 19 2023
End Date
April 30 2024
Last Update
November 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hsinchu Cathay General Hospital
Hsinchu, East Dist, Taiwan, 300